Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-19

Clinical Trial Update: Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ozone-based eye drops as adjuvant therapy for keratitis is in progress with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ozone-based eye drops (ozone-based eye drops)

Snippet

Sponsor: Assiut University | Conditions: Keratitis | Phase 3 | Status: UNKNOWN